<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>According to the classification criteria of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e>, <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>, anticardiolipin and anti-beta(2) <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I antibody assays are independent risk factors for the occurrence of vascular <z:mp ids='MP_0005048'>thrombosis</z:mp> and pregnancy loss </plain></SENT>
<SENT sid="1" pm="."><plain>However, it is generally accepted that patients carrying multiple positivity have more a severe disease and higher recurrence rate despite treatment </plain></SENT>
<SENT sid="2" pm="."><plain>On the other hand, the diagnostic value of a positive result in one only assay is more controversial, particularly in the presence of clinical manifestations such as <z:hpo ids='HP_0002625'>deep vein thrombosis</z:hpo> or early <z:e sem="disease" ids="C0000786" disease_type="Disease or Syndrome" abbrv="">miscarriages</z:e>, which are rather common in the general population </plain></SENT>
<SENT sid="3" pm="."><plain>In this review we speculate on current and future strategies to interpret different <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> profiles in the clinical practice </plain></SENT>
</text></document>